1- Biomed pharma & its parent are market leader in oncology & biology medicines, with 10- years commercial experience and long term strategy to deliver sustainable growth.
2- Our future growth is planned to come from building out into areas including, biosimilars , oncology, immunology and diabetic medicines .
3- Biomed Pharm is a pioneer company ,focused on promoting access and marketing of biosimilars in Yemen .
4- Biosimilars are expected to be our largest growth driver. We are committed to build strong partnerships in this segment and drive sustainable market leadership.
5- Our market offers attractive opportunities, with a growing government and international Agencies support patients .
6- Generics expected to more drive core growth in Yemeni market, biosimilars should accelerate rapidly.